FindTrial
Sign In

to evaluate the effect of Mustadi vati in Stanapeeda with respect to Breast Engorgement in Sutika avastha.

Single arm, open label clinical study to evaluate the effect of Mustadi vati in Stanapeeda with respect to Breast Engorgement in Sutika avastha. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076972
Enrollment
50
Registered
2024-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O922- Other and unspecified disorders ofbreast associated with pregnancy and the puerperium

Interventions

None listed

Sponsors

Sumatibhai Shah Ayurved Mahavidyalya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Purpureal women after vaginal or caesarean section diagnosed with Stanapeeda with respect to Breast Engorgement.

Exclusion criteria

Exclusion criteria: Breast abscess - Breast wound eg. Crack nipples. - Breast Fibroadenoma - Mastitis. - CA Breast and other skin lesions or disease

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Mustadi vati 500mg TDS for consecutive 5days in Stanapeeda with respect to Breast Engorgement.Timepoint: For consecutive 5 days.—

Secondary

MeasureTime frame
To evaluate the effect of Mustadi vati 500mg TDS for consecutive 5days in Stanapeeda with respect to Breast Engorgement.Timepoint: For consecutive 5 days—

Countries

India

Contacts

Public ContactPriyanka Tekriwal

Sumatibhai Shah Ayurved Mahavidyalaya

drkalpanaayare@gmail.com9423295630

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026